Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1994 1
1995 1
2002 1
2003 1
2008 1
2009 1
2010 2
2011 3
2012 5
2013 6
2014 8
2015 8
2016 3
2017 3
2018 1
2019 4
2020 7
2021 5
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
Kakogiannos N, Ferrari L, Giampietro C, Scalise AA, Maderna C, Ravà M, Taddei A, Lampugnani MG, Pisati F, Malinverno M, Martini E, Costa I, Lupia M, Cavallaro U, Beznoussenko GV, Mironov AA, Fernandes B, Rudini N, Dejana E, Giannotta M. Kakogiannos N, et al. Among authors: giannotta m. Circ Res. 2020 Sep 25;127(8):1056-1073. doi: 10.1161/CIRCRESAHA.120.316742. Epub 2020 Jul 15. Circ Res. 2020. PMID: 32673519 Free PMC article.
The blood-brain and gut-vascular barriers: from the perspective of claudins.
Scalise AA, Kakogiannos N, Zanardi F, Iannelli F, Giannotta M. Scalise AA, et al. Among authors: giannotta m. Tissue Barriers. 2021 Jul 3;9(3):1926190. doi: 10.1080/21688370.2021.1926190. Epub 2021 Jun 21. Tissue Barriers. 2021. PMID: 34152937 Free PMC article. Review.
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies.
Pane M, Berti B, Capasso A, Coratti G, Varone A, D'Amico A, Messina S, Masson R, Sansone VA, Donati MA, Agosto C, Bruno C, Ricci F, Pini A, Gagliardi D, Filosto M, Corti S, Leone D, Palermo C, Onesimo R, De Sanctis R, Ricci M, Bitetti I, Sframeli M, Dosi C, Albamonte E, Ticci C, Brolatti N, Bertini E, Finkel R, Mercuri E; ITASMAc group. Pane M, et al. EClinicalMedicine. 2023 May 5;59:101997. doi: 10.1016/j.eclinm.2023.101997. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37197706 Free PMC article.
Distinct neurological disorders with ATP1A3 mutations.
Heinzen EL, Arzimanoglou A, Brashear A, Clapcote SJ, Gurrieri F, Goldstein DB, Jóhannesson SH, Mikati MA, Neville B, Nicole S, Ozelius LJ, Poulsen H, Schyns T, Sweadner KJ, van den Maagdenberg A, Vilsen B; ATP1A3 Working Group. Heinzen EL, et al. Lancet Neurol. 2014 May;13(5):503-14. doi: 10.1016/S1474-4422(14)70011-0. Lancet Neurol. 2014. PMID: 24739246 Free PMC article. Review.
A dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition.
Savorani C, Malinverno M, Seccia R, Maderna C, Giannotta M, Terreran L, Mastrapasqua E, Campaner S, Dejana E, Giampietro C. Savorani C, et al. Among authors: giannotta m. J Cell Sci. 2021 Aug 1;134(15):jcs251371. doi: 10.1242/jcs.251371. Epub 2021 Aug 2. J Cell Sci. 2021. PMID: 34338295 Free PMC article.
Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis.
Nosadini M, Granata T, Matricardi S, Freri E, Ragona F, Papetti L, Suppiej A, Valeriani M, Sartori S; Italian Working Group on Paediatric Anti-N-methyl-D-aspartate Receptor Encephalitis. Nosadini M, et al. Dev Med Child Neurol. 2019 Sep;61(9):1101-1107. doi: 10.1111/dmcn.14267. Epub 2019 Jun 7. Dev Med Child Neurol. 2019. PMID: 31175679 Free article.
67 results